Specializing In:
- Infection control
- Infectious syndromes in immunocompromised hosts
Research Interests:
- Infections in hematopoietic stem cell transplant recipients
- Infections caused by multi-drug resistant organisms in patients with malignancies
- Management of HIV in the setting of HIV-related malignancies
Positions
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology
- Director of Infection Control – Department of Internal Medicine - Infectious Diseases
University of Buffalo Jacobs School of Medicine and Biomedical Sciences
Background
Education and Training
- 2010 - MD - Georgetown University School of Medicine, Washington, DC
Residency
- 2013- University Hospitals/Case Western Reserve University, Cleveland, OH
Fellowship
- 2016 - Cleveland Clinic Foundation, Cleveland, OH
Board Certification
- Internal Medicine, American Board of Internal Medicine
- Infectious Diseases, American Board of Internal Medicine
Professional Memberships
- Infectious Disease Society of America (IDSA)
- Society for Healthcare Epidemiology of America (SHEA)
Publications
Mullin,K et al. A Multifaceted Approach to Reduction of Catheter-Associated Urinary Tract Infections in the Intensive Care Unit With an Emphasis on "Stewardship of Culturing" Infect Control Hosp Epidemiol. 2017 Feb;38(2):186-188. doi: 10.1017/ice.2016.266. Epub 2016 Nov 17. PMID: 27852357
Asadi T, Mullin K, Roselli E, Johnston D, Tan CD, Rodriguez ER, Gordon S. "Disseminated Mycobacterium chimaera infection associated with heater-cooler units after aortic valve surgery without endocarditis." J Thorac Cardiovasc Surg. 2018 Jun;155(6):2369-2374. doi: 10.1016/j.jtcvs.2017.12.049. Epub 2017 Dec 21.
Wasiura J, Segal B, Mullin K. "Cluster of Sphingomonas paucimobilis Bacteremias Linked to Diversion of Intravenous Hydromorphone" N Engl J Med. 2019 Aug 8;381(6):584-585. doi: 10.1056/NEJMc1902973.
Mehta N, Harrington JM, Wallace MA, Wasiura JM, Burnham CD, Mullin KM, Segal BH, Almyroudis NG. "Molecular epidemiology of Clostridioides difficile isolates in a non-outbreak setting at a comprehensive cancer center."Antimicrob Steward Healthc Epidemiol. 2023 Jul 26;3(1):e131. doi: 10.1017/ash.2023.156. eCollection 2023.